GSAT vs JAZZ · rev $134.8M vs P/E 1988, rev $2.28B
Globalstar, Inc. Common Stock (GSAT) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Globalstar, Inc. Common Stock (GSAT) is a telecom services company listed on NASDAQ.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported GSAT revenue for 2026-06-30 was $134.8M. Net income was -$41.4M. Revenue was up 92.4% from 2026-03-31 to 2026-06-30. GSAT currently screens at market cap $10.30B.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
GSAT currently screens at market cap $10.30B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the GSAT and JAZZ stock pages for the full models.
Not investment advice.